• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型蛋白酶体抑制剂NPI-0052对转移性前列腺癌细胞上皮-间质转化的抑制作用:Snail抑制和RKIP诱导的关键作用

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.

作者信息

Baritaki S, Chapman A, Yeung K, Spandidos D A, Palladino M, Bonavida B

机构信息

Department of Microbiology, Immunology and Molecular Genetics, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-736422, USA.

出版信息

Oncogene. 2009 Oct 8;28(40):3573-85. doi: 10.1038/onc.2009.214. Epub 2009 Jul 27.

DOI:10.1038/onc.2009.214
PMID:19633685
Abstract

Metastasis is associated with the loss of epithelial features and the acquisition of mesenchymal characteristics and invasive properties by tumor cells, a process known as epithelial to mesenchymal transition (EMT). Snail expression, through nuclear factor (NF)-kappaB activation, is an EMT determinant. The proteasome inhibitor, NPI-0052, induces the metastasis tumor suppressor/immune surveillance cancer gene, Raf kinase inhibitor protein (RKIP), via NF-kappaB inhibition. We hypothesized that NPI-0052 may inhibit Snail expression and, consequently, the metastatic phenotype in DU-145 prostate cancer cells. Cell treatment with NPI-0052 induced E-cadherin and inhibited Snail expression and both tumor cell invasion and migration. Inhibition of Snail inversely correlated with the induction of RKIP. The underlying mechanism of NPI-0052-induced inhibition of the metastatic phenotype was corroborated by: (1) treatment with Snail siRNA in DU-145 inhibited EMT and, in contrast, overexpression of Snail in the nonmetastatic LNCaP cells induced EMT, (2) NPI-0052-induced repression of Snail via inhibition of NF-kappaB was corroborated by the specific NF-kappaB inhibitor DHMEQ and (3) RKIP overexpression mimicked NPI-0052 in the inhibition of Snail and EMT. These findings demonstrate, for the first time, the role of NPI-0052 in the regulation of EMT via inhibition of NF-kappaB and Snail and induction of RKIP.

摘要

转移与肿瘤细胞上皮特征的丧失以及间充质特征和侵袭特性的获得相关,这一过程称为上皮-间充质转化(EMT)。通过核因子(NF)-κB激活,Snail表达是EMT的一个决定因素。蛋白酶体抑制剂NPI-0052通过抑制NF-κB诱导转移肿瘤抑制因子/免疫监视癌症基因——Raf激酶抑制蛋白(RKIP)。我们假设NPI-0052可能抑制Snail表达,从而抑制DU-145前列腺癌细胞的转移表型。用NPI-0052处理细胞可诱导E-钙黏蛋白表达,抑制Snail表达以及肿瘤细胞的侵袭和迁移。Snail的抑制与RKIP的诱导呈负相关。NPI-0052诱导的转移表型抑制的潜在机制得到以下方面的证实:(1)在DU-145细胞中用Snail小干扰RNA(siRNA)处理可抑制EMT,相反,在非转移性LNCaP细胞中过表达Snail可诱导EMT;(2)特异性NF-κB抑制剂DHMEQ证实了NPI-0052通过抑制NF-κB对Snail的抑制作用;(3)RKIP过表达在抑制Snail和EMT方面模拟了NPI-0052的作用。这些发现首次证明了NPI-0052通过抑制NF-κB和Snail以及诱导RKIP在EMT调控中的作用。

相似文献

1
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.新型蛋白酶体抑制剂NPI-0052对转移性前列腺癌细胞上皮-间质转化的抑制作用:Snail抑制和RKIP诱导的关键作用
Oncogene. 2009 Oct 8;28(40):3573-85. doi: 10.1038/onc.2009.214. Epub 2009 Jul 27.
2
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.蛋白酶体抑制剂NPI-0052抑制蜗牛蛋白和诱导RKIP在肿瘤细胞化学免疫致敏中的关键作用。
Cancer Res. 2009 Nov 1;69(21):8376-85. doi: 10.1158/0008-5472.CAN-09-1069. Epub 2009 Oct 20.
3
The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.癌症中激活的核因子-κB-蜗牛-RKIP信号通路通过细胞毒性药物调节转移级联反应和对细胞凋亡的抗性。
Crit Rev Immunol. 2009;29(3):241-54. doi: 10.1615/critrevimmunol.v29.i3.40.
4
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.NO 供体在逆转肿瘤细胞耐药和 EMT 中的双重作用:NF-κB/Snail/YY1/RKIP 通路的下调。
Nitric Oxide. 2011 Jan 1;24(1):1-7. doi: 10.1016/j.niox.2010.10.001. Epub 2010 Oct 8.
5
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.一氧化氮介导的 EMT 抑制的机制:抑制转移诱导因子 Snail 和诱导转移抑制因子 RKIP。
Cell Cycle. 2010 Dec 15;9(24):4931-40. doi: 10.4161/cc.9.24.14229.
6
The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.阴阳1通过失调的NF-κB/蜗牛/YY1/RKIP/PTEN信号通路在癌症上皮-间质转化调控中的新作用。
Crit Rev Oncog. 2011;16(3-4):211-26. doi: 10.1615/critrevoncog.v16.i3-4.50.
7
Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.吉米沙星抑制人乳腺癌细胞的迁移和侵袭并诱导间质-上皮转化。
J Mol Med (Berl). 2014 Jan;92(1):53-64. doi: 10.1007/s00109-013-1083-4. Epub 2013 Sep 5.
8
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.一氧化氮供体在癌症中的新型治疗应用:在化疗和免疫致敏诱导凋亡及抑制转移中的作用。
Nitric Oxide. 2008 Sep;19(2):152-7. doi: 10.1016/j.niox.2008.04.018. Epub 2008 Apr 24.
9
Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.核因子κB受体激活剂配体(RANKL)的表达与人前列腺癌细胞的上皮-间质转化相关。
Cell Res. 2008 Aug;18(8):858-70. doi: 10.1038/cr.2008.84.
10
The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.抗 CD20 mAb LFB-R603 阻断了 B-NHL 细胞中失调的 NF-κB/Snail/RKIP/PTEN 耐药环:在 TRAIL 凋亡敏化中的作用。
Int J Oncol. 2011 Jun;38(6):1683-94. doi: 10.3892/ijo.2011.984. Epub 2011 Mar 23.

引用本文的文献

1
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic.神经内分泌前列腺癌潜在治疗靶点的新见解:从实验室到临床
Research (Wash D C). 2025 Jul 31;8:0791. doi: 10.34133/research.0791. eCollection 2025.
2
Dietary saturated fatty acids and prostate cancer: insights into NF-κB pathway and lipid metabolism mechanisms.膳食饱和脂肪酸与前列腺癌:对核因子-κB通路及脂质代谢机制的见解
Discov Oncol. 2025 Jun 20;16(1):1166. doi: 10.1007/s12672-025-03005-0.
3
Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma.
树突状细胞相关基因对肺腺癌预后及免疫治疗反应的预测价值
Cancer Cell Int. 2025 Jan 14;25(1):13. doi: 10.1186/s12935-025-03642-z.
4
Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications.Raf 激酶抑制剂蛋白与程序性细胞死亡配体 1 表达在癌症中的串扰:在免疫逃逸中的作用和治疗意义。
Cells. 2024 May 17;13(10):864. doi: 10.3390/cells13100864.
5
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1.YY1对癌症中PD-L1表达的调控:靶向YY1的治疗效果
Cancers (Basel). 2024 Mar 21;16(6):1237. doi: 10.3390/cancers16061237.
6
Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion.二硫代氨基甲酸铋衍生物通过促进线粒体依赖性凋亡途径和抑制 MCF-7 乳腺癌腺癌细胞侵袭来发挥细胞毒性作用。
J Biol Inorg Chem. 2024 Mar;29(2):217-241. doi: 10.1007/s00775-023-02041-x. Epub 2024 Feb 18.
7
Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis.RKIP在胃肠道间质瘤(GIST)中的生物学及治疗意义:一项整合转录组学和蛋白质组学分析
Cancer Cell Int. 2023 Oct 31;23(1):256. doi: 10.1186/s12935-023-03102-6.
8
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer.靶向前列腺癌神经内分泌分化的关键分子。
Int J Mol Sci. 2023 Sep 5;24(18):13673. doi: 10.3390/ijms241813673.
9
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics.天然产物骨架作为潜在蛋白酶体抑制剂在癌症治疗药物研发中的演变
Metabolites. 2023 Mar 31;13(4):509. doi: 10.3390/metabo13040509.
10
Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.克服晚期前列腺癌对新一代激素疗法的原发性和获得性耐药机制:聚焦于雄激素受体非依赖途径。
Cancer Drug Resist. 2020 Sep 12;3(4):726-741. doi: 10.20517/cdr.2020.42. eCollection 2020.